Raltegravir + Rifampin Interaction
Majorinteraction on record
Description
Strong inducer of UGT1A1 that reduces plasma concentrations of raltegravir. Dose adjustment to 800 mg twice daily recommended for ISENTRESS; coadministration not recommended for ISENTRESS HD.
Mechanism
UGT1A1-mediated glucuronidation induction
Source: NLP:raltegravir